Pershing Square Capital
View Older Stories View More Recent Stories
-
Allergan (AGN) Responds to ISS and Glass Lewis Recommendations, Says Offer Still Grossly Inadequate,
-
Glass Lewis Backs Pershing Square's Call for Allergan (AGN) Special Meeting
-
Valeant Pharmaceuticals (VRX), Pershing Call Allergan (AGN) Lawsuit Frivolous
-
Allergan (AGN) Files Complaint Against Valeant (VRX), Pershing Square; Alleges Violation of Securities Laws
-
Allergan (AGN) CEO Pyott: We're Looking to Do Our Own Acquisitions (VRX) (SHPG)
-
Pershing Square Proposes Slate of Six Directors for Allergan (AGN) Board
-
Pershing Square Files Solicitation For Special Meeting of Allergan (AGN) Shareholders
-
Ackman's Pershing Square Gained 25% in H1 2014 (AGN)
-
Pershing Square Taps Top Global Bank in Effort to Bring Valeant (VRX) and Allergan (AGN) Together
-
Valeant Pharma (VRX) on Watch Following Pershing Square, Allergan (AGN) Suit Settlement
-
Pershing Square, Allergan (AGN) Settle 'Poison Pill' Suit
-
Valeant Pharma (VRX) CEO Says Allergan (AGN) Shareholders Support Meeting on Takeover
-
Shire plc (SHPG) Hires Goldman as Adviser - NYT
-
Allergan (AGN) Rejects Unsolicited Exchange Offer from Valeant (VRX)
-
Pershing's Lawsuit Against Alergan (AGN) Fast-Tracked - WSJ
-
Valeant Pharma (VRX) Announces Commencement of Allergan (AGN) Exchange Offer
-
Pershing Square Files Lawsuit Against Allergan (AGN) to Confirm Special Meeting Will Not Trigger Poison Pill
-
Market Wrap: BE Aerospace Plans Split; Valeant, Pershing Square Rejected; New AIG Boss
-
Notable Mergers and Acquisitions of the Day 06/10: (AGN)/(VRX) (BEAV) (PPL) (CLSN)
-
Allergan (AGN) Rejects Revised Offer from Pershing Square, Valeant (VRX)
-
Allergan, Inc. (AGN) Holder Pershing Square Files to Withdraw Prelim. Proxy
-
Market Wrap: Apple Debuts New Software, Apps; Broadcom Looks to Exit BaseBand Business
-
Notable 52-Week Highs and Lows of the Day 06/02: (AGN) (LNG) (DAL) High; (NEON) (BEBE) (WLT) Low
-
Allergan, Inc. (AGN) Responds Pershing Square's Proxy Filing
-
Valeant Pharmaceuticals (VRX), Pershing Square Revise Offer for Allergan; Now $72/Share Cash, 0.82 of Valeant Stock
-
Pershing Square Says Allergan (AGN) Needs Independent Counsel
-
Allergan, Inc., (AGN) Sends Letter to Pershing Square Capital
-
Pershing Square Sends Letter to Allergan, Inc. (AGN); Sees Fault in Rejecting Valeant (VRX) Offer
-
Ackman's Pershing Square Shows New Stakes in Apartment Investment (AINV), Home Properties (HME); Liquidates General Growth Properties (GGP), P&G (PG)
-
Ackman Sends Letter to Allergan's (AGN) Lead Independent Director Gallagher
-
Top 10 News for 04/21 - 04/25: Valeant Makes Big Acquisition; EPS Galore; Netflix Mulls Price Hike
-
Ackman: Pershing Square Exposed to ~$4B of Allergan, Inc. (AGN) Stock
-
Deals, Deals, Deals in Pharmaceutical Sector; Who's Next?
-
Pre-Open Movers 4/22: (RVNC) (AGN) (NFLX) Higher; (MDSO) (BEBE) (RMBS) Lower (more...)
-
Valeant's (VRX) Move to Acquire Allergan (AGN) Makes Sense on Several Fronts - Aegis Capital
-
Jefferies Starts Allergen (AGN) at Hold
-
Valeant (VRX) Enters Cash, Stock Bid for Allergan (AGN)
-
Allergan, Inc. (AGN) Issues Statement on Purported Valeant and Pershing Square Offer
-
After-Hours Movers 4/21: (AGN) (VRX) (NFLX) Higher; (RMBS) (CDNS) (ALSN) Lower (more...)
-
Market Wrap: Next Ford CEO Speculated; Gold Merger Tarnishes; Sarepta Pops on DMD Treatment Timeline
-
Bill Ackman Confirms Valeant (VRX) Merger Plans on Allergan (AGN) - 13D
-
Allergan, Inc. (AGN) Surges on Ackman, Valeant Takeover Interest

